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Objectives. Sjo¨gren’s syndrome (SS) may be complicated by some neurological manifestations, generally sensory polyneuropathy.
Furthermore, involvement of cranial nerves was described as rare complications of SS.Methods. We reported 2 cases: the first one
was a 40-year-old woman who developed neuritis of the left optic nerve as presenting symptom few years before the diagnosis
of SS; the second was a 54-year-old woman who presented a paralysis of the right phrenic nerve 7 years after the SS onset. An
exhaustive review of the literature on patients with cranial or phrenic nerve involvements was also carried out. Results. To the
best of our knowledge, our second case represents the first observation of SS-associated phrenic nerve mononeuritis, while optic
neuritis represents the most frequent cranial nerve involvement detectable in this connective tissue disease. Trigeminal neuropathy
is also frequently reported, whereas neuritis involving the other cranial nerves is quite rare. Conclusions. Cranial nerve injury is a
harmful complication of SS, even if less commonly recorded compared to peripheral neuropathy. Neurological manifestations may
precede the clinical onset of SS; therefore, in patients with apparently isolated cranial nerve involvement, a correct diagnosis of the
underlying SS is often delayed or overlooked entirely; in these instances, standard clinicoserological assessment is recommendable.
1. Introduction
Sjo¨gren’s syndrome (SS) is characterized by chronic inflam-
mation of exocrine glands, such as lachrymal and salivary
glands, leading to xerophthalmia and xerostomia [1]. More-
over, at least one third of patients present with systemic
extraglandular neurological, articular, pulmonary, or gas-
trointestinal manifestations [2]. The prevalence of neuro-
logical manifestations in SS varies between 2% and 60%,
mostly pure or predominantly sensory polyneuropathies
[3]; therefore, a careful neurological evaluation is usually
recommended in the global assessment of SS patients [4].
Apart from central nervous system (CNS) involvement, other
neuropathic patterns are polyradiculopathies, mononeuritis
multiplex, autonomic neuropathies, and cranial neuropathies
[5].These latter are not rarely observed in SS patients, often as
presenting symptom in the absence of overt sicca syndrome
[6, 7], thus the differential diagnosis may be quite difficult.
The pathogenic mechanisms responsible for SS neuro-
logical involvement are unknown. Many hypotheses have
been considered, namely, the direct infiltration of the central
nervous tissue by lymphocytic cells, the vascular injury due
to antineuronal and anti-SSA antibodies, and/or the ischemia
secondary to small vessel vasculitis [8].
In the present paper, we described two patients with SS,
who presentedmononeuritis: the first patient presented optic
neuritis preceding the clinical onset of SS and the second
developed a very unusual neuritis of the right phrenic nerve.
Finally, a review of the literature on cervicocranial neuritis in
the course of SS was carried out.
2. Case Reports
2.1. Case 1. A40-year-old woman referred to our Rheumatol-
ogy Unit in January 2012, in the suspicion of an autoimmune
disorder. Since 2006, she presented episodes of left optic
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mononeuritis, responsive to steroids; thus, she was under-
going a neurologic follow-up for a hypothetical multiple
sclerosis. The first magnetic resonance (MR) of the brain
and the spine showed a solitary T2-hyperintense, gadolinium
enhancing lesion of the retrobulbar and intracanalicular left
optic nerve, suggestive for demyelinated plaque; anyway,
the subsequent yearly MRs did not show other lesions.
Since 2006, positivity for antinuclear antibodies (ANA)
at the titre of 1 : 640 (speckled) was detected, along with
reduced lymphocyte counts (500–600 cells/𝜇L out of 3,500–
4,000 total white cells); the screening for HCV and HBV
infections was negative. Furthermore, since 2007 polyclonal
hypergammaglobulinemia, slight reduction of C3 fraction
of complement, and serum antitransglutaminase and anti-
SSA/SSB autoantibodies were found. However, the patient
did not present a clinically overt sicca syndrome; thus SS
remained misdiagnosed until 2012.
Only after the patient referred to our Rheumatology Cen-
tre, a deeper check-upwas performed, namely, salivary glands
scintigraphy that showed mild salivary hyposecretion basally
and after lemon juice stimulation and Schirmer’s test that
was bilaterally positive (<5mm). On these bases, a diagnosis
of SS, classified according to the new American College of
Rheumatology/Sjo¨gren’s International Collaborative Clinical
Alliance (ACR/SICCA) criteria [9], with recurrent, unilateral
optic neuritis was done. Antibodies targeting aquaporin-4
(NMO antibodies) were not tested for in the serum because
the test was not available; anyway, the patient did not show
acute myelitis or spinal cord MRI lesions. Moreover, the
possibility of optic neuritis not SS-related, but incidental only,
cannot be excluded.
No chronic treatment was prescribed, except steroids in
the case of the further two episodes of mild optic neuritis.
2.2. Case 2. A 54-year-old woman with diagnosis of SS-
scleroderma overlap syndrome from 2005 referred to our
Rheumatology Unit in January 2013. She did not present skin
involvement, while an overt sicca syndrome was observed.
Serum anticentromere autoantibodies were present, with-
out anti-ENA specificity; Schirmer’s test was clearly posi-
tive (<1mm). Videocapillaroscopy revealed an “early” scle-
roderma pattern; salivary glands echography evidenced a
complete atrophy, while chest high-resolution computed
tomography did not show interstitial lung disease, but only
hypotonia of oesophagus. A labial salivary gland biopsy was
not performed, since the patient refused it; thus, the diagnosis
of primary SS, classified according to ACR/SICCA criteria
[9], cannot be formulated.
Since 2012, the patient progressively complained of
fatigue and dyspnoea in the absence of new radiological
pulmonary alterations; therefore, oxygen therapy (3 L/min)
was necessary. Forced vital capacity was 50% of normal value,
whereas heart echography was normal. In November 2012,
the diagnosis of paralysis of right diaphragm was suspected
on the bases of clinical symptoms and radiological alterations
at standard chest X-ray and then confirmed by the detec-
tion of mixed demyelinated/axonal damage of right phrenic
nerve at electromyographic examination. A modest axonal
polyneuropathy of the arms and the legs was also present,
while neck MR excluded compressions of nerve roots. Treat-
ment with steroids at 1mg/kg/day was prescribed without
significant improvement; thus the patient was referred to our
Rheumatology Unit, where an immune-mediated mononeu-
ritis of the right phrenic nerve was suspected. Therapy with
monthly cycles of intravenous immunoglobulin (50 g/day, for
3 consecutive days) was decided. After the third cycle, the
patient experienced reduction of dyspnoea (from 10/10 to 6/10
of modified Borg scale), improved physical performance, and
tapering of daily oxygen therapy, without disease exacerba-
tion up to date.
3. Review of the Literature
An exhaustive revision of the literature was done by including
all case reports and case series of SS patients with cervical-
cranial neuritis present in PubMed database (Table 1); reports
regarding SS associated with other connective tissue diseases
were excluded. Ninety-five reports with a total of 267 SS
patients with different types of cranial neuritis during their
clinical historywere found [4, 7, 10–101];moreover, 68 reports
with available data referred to 160 patients were analyzed in
detail. In particular, the female/male ratio was 20.8, while the
mean age of adult SS patients is 48 ± 13.2 years, consistently
with recent SS epidemiological findings [102, 103]. Four cases
of young girls (range 8–11 years) were also reported, all
affected by optic neuritis and two by CNS involvement [34,
45, 63, 67]. Of interest, considering the 75 cases with available
data, the first episode of cranial neuritis was contemporary to
SS diagnosis in 40% of patients, while neuritis proceeded in
24% (range 1–35 years), or followed SS diagnosis (range 1–14
years) in 36%, respectively.
3.1. Ipo-Anosmia (I CranialNerve). Alterations of the I cranial
nerve were rarely observed; to date, only 4 cases were
described [14, 59]. However, it may be supposable that this
complication is often underdiagnosed or misdiagnosed in SS
patients because of the concomitant olfactory and gustatory
dysfunctions secondary to mucosal dryness.
3.2. Optic Neuritis (II Cranial Nerve). The review of the
literature revealed that optic neuritis represents the 46.4%
(124/267) of cranial neuritis in SS patients [7, 18, 19, 24,
34, 36, 43–45, 49, 54–56, 59, 63, 65–68, 70, 72–75, 77–
81, 83, 85–93, 95–97, 100, 104]; it is often bilateral with
contemporary [65, 67, 68, 70, 85, 89, 95, 97] or sequential
[36, 63] occurrence. In a few cases, neuritis was associated
with CNS involvement, such as brain vasculitis [34, 77],
acute transverse myelopathy [43, 67], myelitis [77, 80, 83, 90],
asepticmeningitis [70], ormultiple sclerosis-like features [80,
91]. Response to treatment was frequently effective, especially
with the use of immunosuppressors; however, an irreversible
visual impairment was occasionally reported [45, 63, 79, 95].
From a pathophysiological point of view, optic neuropathy
may be related to immune-mediated small vessel vasculitis
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[70]; otherwise, it may be due to demyelinating disease being
included or not in the neuromyelitis optica spectrumdisorder
[91].
The majority of published papers refer to case reports.
Among cohort studies, Alexander et al. [18] investigated the
presence of CNS involvement in a cohort of more than 200
SS patients, referring to the John Hopkins Medical Institute
between 1980 and 1983. The 20% of these patients showed
CNS complications, including 16 cases of cranial nerve
involvement. In particular, 7 patients presented transient
monocular optic neuritis, with new episodes of neuritis of
the other eye in 5 cases. Gono et al. in 2011 [91] reported CNS
complications in 56/82 SS patients, 13 of themwith optic neu-
ropathy.The spectrum of clinical features was heterogeneous,
but the majority of patients presented focal or multifocal
alterations preceding the diagnosis of SS. Moreover, the
authors underlined that these disease complications could
mimicmultiple sclerosis features with possible misdiagnoses;
on the other hand, they stressed the importance of screening
SS patients in presence of neurologic manifestations.
3.3. Diplopia (III-IV-VI Cranial Nerves). Diplopia is one of
the most evident features related to alterations of cranial
nerves, namely, oculomotor, trochlear, and abducens. Specific
involvement of the III nerve in SS patients was described in 9
cases [4, 11, 18, 38, 57, 64, 69, 71], of the VI in 7 cases [18, 62],
while only one patient with IV nerve alteration is present in
the literature [47]. Moreover, several other reports illustrated
cases of multiple neuritis including diplopia among the
clinical features [7, 13, 17, 36, 41, 42, 48, 50, 60, 82]. The
prognosis is generally good, with complete resolution within
fewweeks after steroid treatment; however, possible recurrent
episodes have been reported [36, 38, 41, 48].
3.4. Trigeminal Neuropathy (V Cranial Nerve). Trigeminal
injury is the secondmore frequently described feature among
cranial neuritis in SS patients; in fact, trigeminal neuropathy
was observed in 102/267 (38%) cases, isolated or associated
with other cranial nerve involvement [7, 12, 14–18, 20–23,
25, 26, 29–33, 37, 39–42, 44, 46, 50, 51, 53, 58–60, 76, 82,
84, 87, 91, 94, 98, 99]. In 13 cases the neuritis was bilateral
[12, 14, 31, 44, 60, 94], while in 2 it was combined to dorsal
roots ganglionitis [21, 25]. The latter association may suggest
a possible pathogenic mechanism of trigeminal injury that
is an immune-mediated neuron death in the sensory Gasser
ganglion [60]. The prominence of the sensory symptoms
or the presence of several SS patients with pure sensitive
trigeminal neuritis in literature may reinforce this hypothesis
[14, 26, 31, 40, 46].
Considering large cohort studies, Mellgren et al. [29] ret-
rospectively investigated the features of neural involvement
in a cohort of 110 SS patients complicated by neuropathy,
referred to Mayo Clinic between 1976 and 1988. Trigeminal
neuropathy was recorded in 5 patients, generally associated
with sensory motor polyneuropathy. In 2005, Mori et al. [60]
described 92 Japanese patients with SS and neuropathy; to
note, in 93% of cases the diagnosis of SS followed the onset
of neural disorders. Pure sensory trigeminal neuritis affected
15 patients (6 with bilateral involvement), while 5 individuals
showed multiple cranial neuropathy patterns. Overall, the
prevalence of trigeminal neuropathy in SS patients seems to
vary depending on ethnic factors. Anyway, the involvement
of V cranial nerve in the course of SS is not rare; moreover, it
tends to be recurrent or to stabilize and to be less frequently
responsive to steroids than other cranial neuritis [101].
3.5. Facial Palsy (VII Cranial Nerve). In 1935, Henrik Sjo¨gren
himself was the first author to mention cranial nerve involve-
ment in SS patients, describing a case with bilateral facial
palsy [9]; up to date, other 13 cases were described [18,
28, 35, 52, 59–61, 78, 86, 91], with bilateral involvement in
only one patient [28]. In other cases, facial involvement
presented asmultiple cranial neuritis [7, 13, 17, 48, 82], usually
associated with trigeminal and/or glossopharyngeal nerve
injury, generally responsive to steroid treatment.
3.6. Tinnitus (VIII Cranial Nerve). Neuropathy of the
cochlear nerve is rarely reported in the literature. Except one
[41], they were described as isolated involvement [4, 18, 59].
Significant data regarding prognosis were lacking.
3.7. Involvement of IX, X, XI, and XII Cranial Nerves. A
few reports described SS patients who presented difficulty
of swallowing, which is a symptom of glossopharyngeal
neuropathy [13, 17, 36, 48, 51, 60, 76, 91]; this nerve involve-
ment was always reported in cases of multineuritis. Also the
vagus and the hypoglossal nerves were rarely mentioned in
the literature and invariably associated with the IX cranial
nerve [48, 51, 60, 76, 91]. All cases seem to be related to
transient, often recurrent episodes of multineuritis, generally
responsive to treatment. Finally, the XI nerve involvement
was never reported.
3.8. Phrenic Nerve Involvement. Phrenic nerve is not a cranial
nerve; it originates in the neck from C3–C5 cervical nerves,
containing motor efferent fibres to diaphragm and sensitive
fibres from pericardium and visceral pleura.
The research in PubMed database of “Phrenic nerve” and
“Sjo¨gren’s syndrome” did not find any report. Furthermore,
considering other autoimmune rheumatic diseases, few anec-
dotal reports regarding phrenic nerve involvement in sys-
temic lupus erythematosus [105–108] or ANCA-associated
vasculitides [109–112] were found. Up to date, diaphragm
paralysis is very rarely associated with autoimmune dis-
orders; therefore we cannot exclude that the present case
number 2 represents a casual association with SS than SS-
related.
4. Discussion
In the present report, two SS patients with optic and phrenic
mononeuritis were described. The coexistence of a cranial
neuritis in the course of SS is in keeping with the world
literature reporting a number of anecdotal cases and a few
cohort studies describing SS patients with cranial neuritis
[4, 7, 10–101]; however, to the best of our knowledge, our
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Table 1: Review of the literature regarding Sjo¨gren’s syndrome (SS) patients with cranial neuritis.
First authors/year Ref. No. pts. Age/gender
Onset of neuritis
versus diagnosis of
SS (years)∗
Nerves
involved/clinical
features
Follow-up
Sjogren/1935 [10] 1 n.d. n.a. bil. VII n.a.
Weber/1945 [11] 1 n.a. n.a. III n.a.
Spillane/1959 [12] 1 58 F n.a. bil. V n.a.
Attwood/1961 [13] 1 50 F n.a. III–V–VII–IX Improv. with Cs
Kaltreider/1969 [14]
4 45 F, 48 F,52 F, 73 F
+6; +2;
+5; +14
sV (3), bil. (pt. 3); bil.
I + PNS involv. (pt. 4)
1: chronic course, onset during Cs; 2, 4:
Cs inefficacy; 3: response to Cs
1 55 F +8 I remission within 1 year
Whaley/1972 [15] 1 27 F n.a. V Response to Cs and P.E.
Hull/1984 [16] 1 33 F 0 V + PNS n.a.
Vincent/1985 [17] 1 53 F +7 V–VII–IX-diplopia Recurrent ep. (6 in 7 years)
Alexander/1986 [18] 16 Mean 50 F n.a. 7 II, 2 III, 1 V, 6 VI, 1VII, 1 VIII n.a.
Shimode/1986 [19] 1 n.a. n.a. II n.a.
Serratrice/1986 [20] 1 58 F +4 V Cs 20mg/day ineffective
Malinow/1986 [21] 1 F n.a. V + d.r. ganglionitis n.a.
Mauch/1994 [22] 1 n.a. n.a. V n.a.
Hankey/1987 [23] 1 78 F + (several years) V + PNS involv. n.a.
Wise/1988 [24] 3 F − (1–6) II n.a.
Laloux/1988 [25] 1 81 F n.a. V + d.r. ganglionitis n.a.
Graus/1988 [26] 2 58 F, 75 F n.a. sV n.a.
Phanthumchinda/
1989 [27] 1 28 F 0 Multiple Resolved with Cs
Uchihara/1989 [28] 1 n.a. n.a. bil. VII n.a.
Mellgren/1989 [29] 5 n.a. n.a. V n.a.
Andonopoulos/
1990 [30] 3 n.a. n.a. V n.a.
Flint/1990 [31] 1 n.a. n.a. bil. sV n.a.
Mukai/1990 [32] 5 n.a. n.a. V n.a.
Semah/1990 [33] 1 57 F −11 V Chronic course
Berman/1990 [34] 1 10 F 0 II + CNS vasculitis Improv. with immunosuppressors
Berault-
Dupont/1992 [35] 1 59 F 0 VII Improv. to high dosage Cs
Tesar/1992 [36] 3 20 F, 35 F, 41 F 0; −1; −2
II, bil. III-IV–VI (pt.
1), bil. II (pt. 2),
II–IX-diplopia + CNS
involv. (pt. 3)
Resolution with high dosage Cs (pt. 1);
improv. with high dosage Cs (pt. 2);
recurrent, resolution of neuritis with
Cs/CYC within 6 months (pt. 3)
Soubrier/1993 [37] 4 n.a. n.a. V n.a.
Pou Serradell/1993 [38] 1 63 F − (n.a.) III (8 ep.), multiple(5 ep.) Recurrent, responsive to Cs
Gu¨ell/1993 [39] 1 n.a. 0 V n.a.
Mauch/1987 [40] 1 n.a. n.a. sV n.a.
Bakouche/1994 [41] 1 49 M − (n.a.) Diplopia-V-tinnitus Recurrent (3 ep.) solving within 3 weeks
Matsukawa/1995 [42] 1 56 F 0 V then IV–VI The first ep. autoresolved; the second withCs
Harada/1995 [43] 1 n.a. − (n.a.) II + acute transv.myelopathy Resistant to Cs
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Table 1: Continued.
First authors/year Ref. No. pts. Age/gender
Onset of neuritis
versus diagnosis of
SS (years)∗
Nerves
involved/clinical
features
Follow-up
Tajima/1997 [44] 9 Mean 54.9 F; 51F n.a. 8 V, 4 bil.; 1 II n.a.
Rojas-
Rodriguez/1998 [45] 1 8 F − (n.a.) II
Visual impairment not responsive to Cs,
IVIG, CYC pulses
Govoni/1999 [4] 2 51 F, 24 F +6; +2 VIII; III + cerebellarataxia n.a.
Dumas/1999 [46] 1 41 F n.a. sV n.a.
Kuhl/1999 [47] 1 54 F +8 IV Improv. spontaneously within few weeks
Touze/1999 [48] 1 34 F (first ep.) −35; −2; 0;+2; + (n.a.) VI, VII, IX, laryngeal Recurrent ep., not improv. with Cs
Oketani/1999 [49] 1 52 F +2 II Improv. to pulse Cs
Wingerchuk/1999 [104] 4 n.a. n.a. II n.a.
Chu/2000 [50] 1 54 F 0 IV-V Resolution with Cs and Aza within 4weeks
Urban/2001 [51] 1 53 F +1 V–IX-X Chronic course
Hadithi/2001 [52] 1 41 F 0 VII Autoresolution after several days
Lafitte/2001 [53] 1 n.a. n.a. V n.a.
Kadota/2002 [54] 1 63 F 0 II Autoresolution within 6 months
Maeda/2002 [55] 1 21 F 0 II Autoresolution
Anaya/2002 [56] 1 n.a. n.a. II n.a.
Yanagihara/2002 [57] 1 39 F 0 III n.a.
Font/2003 [58] 6 Mean 58 F −4 to 0 V Chronic course besides oral Cs
Delalande/2004 [59] 30 n.a. n.a. 2 I, 13 II, 5 V, 4 VII, 6VIII n.a.
Mori/2005 [60] 20 Mean 55.6 − (n.a.)
15 V, 1 VII, 5 multiple
(III, V, VI, VII, IX, X,
XII)
4/7 patients improv. with Cs
Rousso/2005 [61] 1 40 F 0 VII Recurrent ep. that autoresolved, in 1 pt.with Cs/vit. B12 within 12 days
Oishi/2007 [62] 1 65 M 0 VI Autoresolved within 5 months
Cardoso/2006 [63] 1 9 F −9; 0 bil. II 2 ep. 9 years apart, irreversible visual lossafter initial response to Cs
Galbussera/2007 [64] 1 79 F 0 III Resolution with Cs and IGIV within 2months
Pournaras/2007 [65] 1 38 M 0 bil. II Improv. with Cs
Go¨kc¸ay/2007 [66] 1 20 F −10 II Cs/Aza resistant, switch to CYC
Arabshahi/2006 [67] 1 11 F 0 bil. II + transv.myelitis Recurrent ep., transient improv. with Cs
Barroso/2007 [68] 1 34 F −9 II + CNS involv. Recurrent ep., responsive to iv Cs
Teo/2008 [69] 1 52 F 0 III n.a.
Be´jot/2008 [70] 1 53 F + (n.a.) bil. II + asepticmeningitis Improv. with CYC
Lui/2008 [71] 1 59 M 0 III Resolved with Cs/Aza within 2 weeks
Ii/2008 [72] 1 49 F 0 II Improv. with IVIG
Javed/2008 [73] 2 n.a. n.a. II n.a.
Pittock/2008 [74] 6 n.a. n.a. II n.a.
Min/2009 [75] 6 n.a. n.a. II n.a.
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Table 1: Continued.
First authors/year Ref. No. pts. Age/gender
Onset of neuritis
versus diagnosis of
SS (years)∗
Nerves
involved/clinical
features
Follow-up
Ashraf/2009 [76] 1 47 F 0 V–IX–XII Resolved with Cs and MTX
Kato/2009 [77] 1 25 F + (2) II + CNS involv. Improv. with high-dosage Cs
Dellavance/2009 [78] 2 n.a. n.a. II n.a.
Kim/2009 [79] 7 n.a. n.a. II Poor prognosis for high relapse rate
Alhomoud/2009 [80] 10 Mean 40 F n.a. 9 II + CNS involv.; 1VII n.a.
Rabadi/2010 [81] 1 23 F 0 II n.a.
Sakai/2010 [82] 1 77 M 0 III-bil.V-VI-VII Improv. with Cs
Imbe/2010 [83] 1 31 F 0 II + acute myelitis Improv. with Cs/P.E.
Nascimento/2010 [84] 2 n.a. −10; −0.5 V n.a.
Chourkani/2010 [85] 2 43 F, 48 F 0 II (bil. 1 pt.) Improv. with Cs/immunosuppressors
Massara/2010 [86] 3 48, 50, 74 F +5, +6,+16 years later 2 II, 1 VII Resolution with iv Cs
Cojocaru/2011 [87] 1 50 F +0.7; +2 II then V 1
∘ ep.: improv. with Cs/IVIG; 2∘ ep.:
Cs-resistant
Nit¸escu/2011 [88] 2 n.a. + (n.a.) II n.a.
Yadav/2011 [89] 1 26 F + (several years) bil. II n.a.
Koga/2011 [90] 1 31 F 0 II + acute myelitis Improv. with P.E., Cs-resistant
Gono/2011 [91] 7 Mean 44 F n.a. 3 II (1 + CNS involv.),2 V, 1 VII, 1 IX-X n.a.
Kolfenbach/2011 [92] 6 n.a. n.a. II Recurrent ep.
Estiasari/2012 [93] 10 n.a. n.a. II n.a.
Horai/2012 [94] 8
63 F, 52 M, 43 F,
61 F,
51 F, 55 F, 45 F,
35 F
0 (first case); n.a. V (4 bil.)
Improv. with Cs/tacrolimus (1); Improv.
with Cs (1);
Improv. with symptomatic treat (3); resist.
to Cs (1);
recurrent (1)
Tan/2012 [95] 1 56 F 0 bil. II Permanent visual impairment
Maruta/2012 [96] 1 89 F 0 II Improv. with iv Cs
Mallucci/2012 [97] 1 74 F 0 bil. II n.a.
Teixeira/2013 [7] 4 Mean 47.9 F n.a. 2 II, V, VI, 2 VII Cs almost effective
Briani/2013 [98] 1 66 F +5 V n.a.
Flanagan/2013 [99] 1 64 M 0 V n.a.
Tang/2013 [100] 8 Mean 34.7 F 0 II Recurrent (3 pts), response toCs/immunosuppressors
Present cases 2 40 F, 54 F −6; +8 II; phrenic nerve Improvement with Cs (40 F), with IVIG(54 F)
TOTAL 267
F/M: 20.8 Mean
age: 48 ± 13.2
years
4 I, 123 II, 8 III, 4 IV,
95 V, 17 VI, 23 VII, 9
VIII, 11 IX, 8 X, 0 XI,
6 XII (§)
(∗) 0: diagnosis of SS and neuritis were contemporary; + (yrs): neuritis onset after diagnosis of SS; − (yrs): neuritis onset before diagnosis of SS. (§) for each
cranial nerve, all cases of documented involvement have been counted, even if they are included in episodes of multineuritis; therefore the total of SS patients
with neuritis does not correspond to the total number of episodes with cranial nerve involvements. n.a. = not available; CNS = central nervous system; PNS
= peripheral nervous system; bil. = bilateral; involv. = involvement; sV = pure sensory trigeminal involvement; d.r. ganglionitis = dorsal roots ganglionitis;
transv. = transverse; ep. = episode; pt. = patient; Cs = corticosteroids; CYC = cyclophosphamide; Aza = azathioprine; IMTX =methotrexate; VIG = intravenous
immunoglobulins; P.E. = plasma exchange.
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Table 2: Synoptic view of cranial nerve involvement in the course of Sjo¨gren’s syndrome (SS).
Cranial
nerve(s)
Frequency of
involvement (%) Key points
I 1 Probably underdiagnosed because of the concomitant olfactory dysfunction secondary to mucosaldryness.
II 46 Possible feature of neuromyelitis optica spectrum disorder, associated with SS, otherwise,autoimmune neuritis in patients with possibly misdiagnosed SS.
III, IV, VI 12 Clinically evident as diplopia, this neuritis is generally responsive to steroids.
V 38 Autoimmune damage of the Gasser ganglion could be suspected. Neuritis tends to be recurrent or tostabilize and to be less frequently responsive to steroids than other cranial neuritis.
VII 5 Neuritis isolated or associated with another nerve involvement, with good prognosis.
VIII 3 Neuritis rarely reported as tinnitus, often isolated.
IX, X, XI, XII 4 Transient, often recurrent neuritis episodes, generally responsive to steroids. The IX nerve wasalways reported in cases of multineuritis, while the XI was never mentioned in literature.
Cranial nerves are named with their Roman numerals. The frequencies of involvement refer to the cases illustrated in Table 1, considering a total of 267 SS
patients with cranial neuritis.
observation of phrenic mononeuritis represents the first
patient with SS complicated by such peculiar manifestation.
Involvement of cranial nerves in SS is much less common
with respect to peripheral neuropathy [91]; however, cranial
neuritis may be considered relatively frequent among central
nervous system neuropathic patterns (Table 2). It is not
always clear whether optic neuritis, a demyelinating disease
characterized by significant morbidity in more than 90% of
cases [95], is secondary or coincidental with SS; anyway,
both SS and optic neuritis seem to be autoimmune-driven
disorder [60, 91, 93, 97]. In this respect, neuromyelitis optica
(NMO), also named Devic’s disease, is a heterogeneous dis-
ease, characterized by chronic demyelinating inflammation
of the optic nerve and the spinal cord, mostly characterized
by the presence of antibodies targeting aquaporin-4 (NMO
antibodies) with a specificity of 90% [113]; this autoantigen,
expressed on astrocytes in a perivascular distribution, rep-
resents a water channel regulating the water homoeostasis
in the central nervous system [114]. Initially considered
as a localized form of multiple sclerosis, NMO is now
classified as independent nosologic entity [115]; in 2006,
modified diagnostic criteria were proposed [116], including
the presence of optic neuritis, acute myelitis, and at least 2
out of the 3 following supportive criteria: contiguous spinal
cord MRI lesion extending over ≥3 vertebral segments, brain
MRI not meeting diagnostic criteria for multiple sclerosis,
and NMO-IgG seropositive status. A few cases reported in
the literature regarding SS patients with optic neuritis may
be diagnosed as NMO [83, 90, 113]; indeed, many of the “SS
optic neuritis” patients were described prior to the discovery
of the NMO antibodies, and therefore many of these cases
may actually represent NMO, and not SS-related. On the
other hand, in the study byWingerchuk et al. [104] among 71
subjects withNMO, 4 patients affected by SSwerementioned;
therefore, we may assume that SS and NMO could represent
comorbidity. Interestingly, the presence of NMO antibodies
in SS patients has been described [75, 93, 95, 97], possibly
as expression of polyclonal B cell activation typical of SS
[95]; on the other hand, patients with NMO frequently
have other autoantibodies of a variety of specificities, and
among the commonest of these autoantibodies are SSA and
SSB [74]. A comparable autoimmune mechanism against
both protein sequences of aquaporin-4 (antigen specific for
NMO) and aquaporin-5 (expressed in salivary glands) [113]
could be hypothesized, even if evidences are still lacking.
In these lights, a rheumatologic screening for latent SS is
recommendable in patients with apparently isolated optic
demyelinating lesions or already classified as NMO.
Apure sensory trigeminal neuropathy has been described
in patients with SS [14, 26, 31, 40, 46]. Since the trigeminal
sensory neurons conducing cutaneous stimuli are located
in the Gasser ganglion, damage at this level is suspected.
This hypothesis is supported by the study of Valls-Sole et al.
[117], who carried out an electrophysiological study of the
trigeminal-facial and trigeminal-trigeminal reflexes in 5 SS
patients with pure sensory neuropathy, compared to subjects
with sensory-motor neuropathies from other causes and to
healthy controls. SS patients with pure sensory neuropathy
specifically presented an abnormal blink reflex and a normal
jaw jerk. These findings suggest that the damage involves the
neurons of the Gasser ganglion and not the axons of the V
cranial nerve.
In many cases described in literature, as well as in
our patient number 1, SS was diagnosed contemporary or
even after the onset of cranial neuritis. These patients are
commonly referred to neurology or ophthalmology centres,
where sicca syndrome or other SS manifestations, such as
arthralgias and/or mild arthritis, may be underestimated or
not even mentioned by the patients. Consequently, a correct
diagnosis of the underlying connective tissue disease is often
delayed or overlooked entirely. Nonetheless, patients with
CNS involvement and/or optic neuritis may bemisdiagnosed
as multiple sclerosis. Thus, in patients with cranial nerve
involvement it is recommendable to keep in mind the
possibility of associated SS that may be easily diagnosed by
standard clinicoserological assessment.
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With regard to our patient number 2, the diagnosis of
overlapping SS and systemic sclerosis was based on the pres-
ence of typical SS clinicalmanifestations, plus anticentromere
autoantibodies, esophagus involvement, and scleroderma
capillaroscopic pattern [118]. Yet, the typical anti-SSA/SSB
autoantibodies were not found, nor a lip biopsy was carried
out to ascertain the diagnosis of SS. Anyway, on the basis on
the symptom complex described above, the patient might be
included in the subset of patients with the so-called “ACA-
positive limited scleroderma/SS overlap syndrome,” which is
characterized by benign scleroderma clinical course but at a
high risk of non-Hodgkin’s lymphoma [119]. Interestingly, an
increased frequency of peripheral neuropathy in this peculiar
clinical subset has been previously reported [120]. In regard
to the phrenic nerve involvement, this might represent a
limited form of brachial plexopathy, in the context of a
diffuse immune-mediated polyneuropathy, given the absence
of brachial plexus injury at neck MR.
In conclusion, SS patients may be affected by cranial
neuropathy, mainly optic neuritis or trigeminal neuropathy,
which could represent the first symptom of subclinical
connective tissue disease. In addition, the first observation
of phrenic neuritis in a woman affected by SS and sclero-
derma in overlap was also described. Overall, careful clinical
evaluation is recommendable in such conditions, particularly
in individuals with apparently isolated cervicocranial nerve
involvement.
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